|
| Ref |
|
| ASC-G | |
| Quasidrug principal ingredient in skin care products | [3] |
| Food additive | [3] |
| Medical additive in commercial cosmetics | [3] |
| Skin antioxidant | [10] |
| Prevention of sinusoidal endothelial cell apotosis in preserved graft | [10] |
| High stability against thermal and oxidative degradation | [9] |
| Rapid conversion to ascorbic acid by α-glucosidase in the blood | [10] |
| Solubilization of clarithromycin (CAM) | [11] |
| Nanoparticle formation of CAM | [11] |
| Stabilization of CAM nanosuspension | [11] |
|
| ASC-8 | |
| Solubilization of phenacetin, danthron, anthralin, and retinoic acid | [12] |
| Solubilization capacity of anthralin: ASC-8 < −10 < −12 < −14 < −16 | [12] |
|
| ASC-P | |
| Cosmetic ingredients | [5] |
| Solubilization of drug | [5] |
| Decrease viscosity of gel formulation | [5] |
| Skin moisturizing and penetration effect of ASC-P entrapped in SLN, NLC, and NE incorporated into hydrogel | [21] |
| Antioxidant | [17–20, 23] |
| Stabilization of ASC-P by encapsulation in PLA nanoparticles | [22] |
| Skin permeation enhancer | [24] |
| Cytotoxicity against cancer cell | [25, 26] |
| ASC-P vesicles (Aspasomes) | [28] |
|
| ASC-S | |
| Cosmetic ingredients |
*
|
| Cytotoxicity against cancer cell | [27] |
|
| ASC-DP | |
| Cosmetic ingredients |
*
|
| Antioxidant (skin whitening action) | [29] |
| Extended the stability of adhesive transdermal pharmaceuticals | [29] |
| Nanoparticle formation with DSPE-PEG | [31] |
| Drug encapsulation in ASC-DP/DSPE-PEG | [31] |
|
